Tuberculosis and drug resistance in Iran


avatar Batool Sharifi-Mood 1 , * , avatar Roya Alavi-Naini 1 , avatar Maliheh Metanat 1

Associate Professor of Infectious disease, Research Center of Infectious disease and Tropical Medicine, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran.

how to cite: Sharifi-Mood B , Alavi-Naini R, Metanat M. Tuberculosis and drug resistance in Iran. Zahedan J Res Med Sci. 2010;12(3):e94292.


  Background : Tuberculosis is a great health issue in developing countries. Drug resistance is one of the principal problems in treating TB patients. In this review article we tried to demonstrate the prevalence of Multiple Drug Resistance (MDR), Extensively Drug Resistance (XDR) and Totally Drug Resistance (TDR) in tuberculosis patients in Iran.
  Materials and Method : We used PUBMED, Scopus and scientific Iranian journals from the year 1970 to February 2010 for extracting data. Key words such as tuberculosis, drug resistance and Iran were used.
  Results : There were several articles in this context but only articles in which Multiple Drug Resistance, Extensively Drug Resistance and Totally Drug Resistance tuberculosis were used were studied. The prevalence of MDR in several provinces of Iran was 0.5 to 27.9%. In Massih Daneshvari Hospital the prevalence of MDR and XDR were 5.4 and 10.6%, respectively.
  Conclusion : The results of the study revealed that the rate of MDR is increasing in Iran. The appearance of XDR and TDR are serious threats in the control and treatment of tuberculosis.


The full text of this article is available on the PDF file.



  • 1.

    The References of this article are available on the PDF file.

© 2010, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.